Literature DB >> 30142649

Accurate Assessment of Blood Loss during Cesarean Delivery Improves Estimation of Postoperative Hemoglobin.

Andrew F Rubenstein1, Michael Block2, Stacy Zamudio3, Claudia Douglas4, Sharon Sledge5, Griffeth Tully6, Robert L Thurer6.   

Abstract

OBJECTIVE: To determine if accurate blood loss determination during cesarean delivery can improve the prediction of postoperative hemoglobin levels. STUDY
DESIGN: This is a retrospective cohort study using visually estimated blood loss (traditional, n = 2,025) versus estimates using a mobile application that photographs sponges and canisters and calculates their hemoglobin content (device, n = 756).
RESULTS: The correlation between the actual and predicted postoperative day 1 hemoglobin value (PPO1 Hgb) was better in the device group (R 2 = 0.519, correlation = 0.720) than in the traditional group (R 2 = 0.429, correlation = 0.655) (p = 0.005). For patients in the device group where the estimated blood loss was >1,000 mL (n = 53), the PPO1 Hgb was also better correlated with the actual value (R 2 = 0.319, correlation = 0.565) than the predictions using visually estimated blood loss for those patients in the device group whose visual estimation was >1,000 mL (n = 32) (R 2 = 0.035, correlation = 0.187) (p = 0.027).
CONCLUSION: Implementation of a device that accurately measures blood loss allows for a better prediction of postoperative day 1 hemoglobin concentration than is possible using visual blood loss estimation. This improvement was seen in the entire patient group and was particularly prominent in patients with blood losses of > 1,000 mL. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30142649     DOI: 10.1055/s-0038-1669397

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  1 in total

1.  Do we visually estimate intra-operative blood loss better with white or green sponges and is the deviation from the real blood loss clinically acceptable? Results from a simulated scenario study.

Authors:  Florian Piekarski; Lara Gerdessen; Elke Schmitt; Linda Tanner; Florian Wunderer; Vanessa Neef; Patrick Meybohm; Kai Zacharowski; Florian Jürgen Raimann
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.